Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:8 Issue:10 Number:27 ISSN#:2564-2537
ACE Report #12048
Ace Report Cover Shoulder & Elbow

OTA 2019: Health outcomes of nonoperative vs operative treatment for distal clavicle fractures

How to Cite

OrthoEvidence. OTA 2019: Health outcomes of nonoperative vs operative treatment for distal clavicle fractures. ACE Report. 2019;8(10):27. Available from: https://myorthoevidence.com/AceReport/Report/12048

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

General Health Outcomes Following Distal Clavicle Fractures: Results From a Previous Randomized Controlled Trial

Contributing Authors: C Schemitsch MD McKee N Dehghan EH Schemitch A Nauth M Vicente J Hall

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.


57 patients with displaced, distal clavicle fractures were randomized to receive surgical treatment or conservative treatment. The outcomes of interest included the Short Form 36 Mental and Physical Component Scores (SF-36 MCS; SF-36 PCS). A regression analysis was performed to determine whether baseline characteristics predict general health status at 2 years. Results revealed no significant diff...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.